The impact of ventral noradrenergic bundle lesions on increased IL-1 in the PVN and hormonal responses to stress in male Sprague Dawley rats

Endocrinology

Volumn 154, Issue 7, 2013, Pages 2489-2500

  Blandino, Peter ^a   Hueston, Cara M ^a   Barnum, Christopher J ^a   Bishop, Christopher ^a   Deak, Terrence ^a  

^a BINGHAMTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; CYCLOOXYGENASE 2; DOPAMINE; INTERLEUKIN 1; INTERLEUKIN 1BETA; MONOAMINE; NORADRENALIN; OXIDOPAMINE; PROTEIN C FOS; SEROTONIN;

ACUTE STRESS; ADRENAL GLAND; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; CORTICOSTERONE RELEASE; CORTICOTROPIN BLOOD LEVEL; DOPAMINE BRAIN LEVEL; ENDOCRINE FUNCTION; FOOTSHOCK; HYPOPHYSIS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; NORADRENALIN BRAIN LEVEL; NORADRENERGIC SYSTEM; NUCLEOTIDE SEQUENCE; PARAVENTRICULAR THALAMIC NUCLEUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEROTONIN BRAIN LEVEL; SIGNAL TRANSDUCTION; STRESS; THYMUS; VENTRAL NORADRENERGIC BUNDLE;

EID: 84879293154     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1075     Document Type: Article

References (60)

1. Dunn AJ. Cytokine activation of the HPA axis. Ann NY Acad Sci. 2000;917:608-617.
2. Ovadia H, Abramsky O, Barak V, Conforti N, Saphier D, Weidenfeld J. Effect of interleukin-1 on adrenocortical activity in intact and hypothalamic deafferentated male rats. Exp Brain Res. 1989;76(1):246-249. (Pubitemid 19167238)
3. Ericsson A, Kovacs K, Sawchenko P. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci. 1994;14(2):897-913. (Pubitemid 24043940)
4. Haddad JJ, Saadé NE, Safieh-Garabedian B. Cytokines and neuroimmune-endocrine interactions: a role for the hypothalamic-pituitary- adrenal revolving axis. J Neuroimmunol. 2002;133(1-2):1-19. (Pubitemid 35346723)
5. Hermoso MA, Cidlowski JA. Putting the brake on inflammatory responses: the role of glucocorticoids. IUBMB Life. 2003;55(9):497-504. (Pubitemid 37462705)
6. Quan N, He L, Lai W, Shen T, Herkenham M. Induction of IκBα mRNA expression in the brain by glucocorticoids: a negative feedback mechanism for immune-to-brain signaling. J Neurosci. 2000;20(17):6473-6477.
7. Duncan MR, Sadlik JR, Hadden JW. Glucocorticoid modulation of lymphokine-induced macrophage proliferation. Cell Immunol. 1982;67(1):23-36. (Pubitemid 12189626)
8. Goujon E, Parnet P, Layé S, Combe C, Dantzer R. Adrenalectomy enhances pro-inflammatory cytokines gene expression, in the spleen, pituitary and brain of mice in response to lipopolysaccharide. Mol Brain Res. 1996;36(1):53-62. (Pubitemid 26058875)
9. Blandino P Jr, Barnum CJ, Solomon LG, Larish Y, Lankow BS, Deak T. Gene expression changes in the hypothalamus provide evidence for regionally-selective changes in IL-1 and microglial markers after acute stress. Brain Behav Immun. 2009;23:958-968.
10. McClellan JL, Klir JJ, Morrow LE, Kluger MJ. Central effects of glucocorticoid receptor antagonist RU-38486 on lipopolysaccharide and stress-induced fever. AmJ Physiol. 1994;267(3 Pt 2):R705-R711.
11. Giannotta SL, Weiss MH, Apuzzo MLJ, Martin E. High dose glucocorticoids in the management of severe head injury. Neurosurgery. 1984;15(4):497-501. (Pubitemid 14022007)
12. Da Silva JAP, Jacobs JWG, Kirwan JR, et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis. 2006;65(3):285-293. (Pubitemid 43268214)
13. Goldsmith P, McGarity B, Walls AF, Church MK, Millward-Sadler GH, Robertson DAF. Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease. Dig Dis Sci. 1990;35(11):1409-1413. (Pubitemid 20377973)
14. Turpeinen M, Nikander K, Pelkonen AS, et al. Daily versus as-needed inhaled corticosteroid for mild persistent asthma (The Helsinki Early Intervention Childhood Asthma study). Arch Dis Child. 2008;93(8):654-659.
15. Deak T, Bellamy C, D'Agostino LG. Exposure to forced swim stress does not alter central production of IL-1. Brain Res. 2003;972(1-2):53-63. (Pubitemid 36507077)
16. Deak T, Bordner KA, McElderry NK, et al. Stress-induced increases in hypothalamic IL-1: a systematic analysis of multiple stressor paradigms. Brain Res Bull. 2005;64(6):541-556. (Pubitemid 40082506)
17. Hueston CM, Barnum CJ, Eberle JA, Ferraioli FJ, Buck HM, Deak T. Stress-dependent changes in neuroinflammatory markers observed after common laboratory stressors are not seen following acute social defeat of the Sprague Dawley rat. Physiol Behav. 2011;104:187-198.
18. Nguyen KT, Deak T, Owens SM, et al. Exposure to acute stress induces brain interleukin-1b protein in the rat. J Neurosci. 1998;18(6):2239-2246. (Pubitemid 28141428)
19. Nguyen KT, Deak T, Will MJ, et al. Time course and corticosterone sensitivity of the brain, pituitary, and serum interleukin-1β protein response to acute stress. Brain Res. 2000;859(2):193-201. (Pubitemid 30136088)
20. Sawchenko PE, Swanson LW. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res. 1982;257(3):275-325. (Pubitemid 13224880)
21. Swanson LW, Hartman BK. The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. J Comp Neurol. 1975;163(4):467-505.
22. Gaillet S, Alonso G, Le Borgne R, et al. Effects of discrete lesions in the ventral noradrenergic ascending bundle on the corticotropic stress response depend on the site of the lesion and on the plasma levels of adrenal steroids. Neuroendocrinology. 1993;58(4):408-419. (Pubitemid 23330187)
23. Gaillet S, Lachuer J, Malaval F, Assenmacher I, Szafarczyk A. The involvement of noradrenergic ascending pathways in the stress-induced activation of ACTH and corticosterone secretions is dependent on the nature of stressors. ExpBrain Res. 1991;87(1):173-180.
24. Feldman S, Conforti N, Melamed E. Involvement of ventral norad-renergic bundle in corticosterone secretion following neural stimuli. Neuropharmacology. 1988;27(2):129-133. (Pubitemid 18052353)
25. Li HY, Ericsson A, Sawchenko PE. Distinct mechanisms underlie activation of hypothalamic neurosecretory neurons and their medullary catecholaminergic afferents in categorically different stress paradigms. Proc Natl Acad Sci USA. 1996;93(6):2359-2364. (Pubitemid 26104355)
26. Palkovits M. Interconnections between the neuroendocrine hypothalamus and central autonomic system. Front Neuroendocrinol. 1999;20:270-295. (Pubitemid 29491841)
27. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 6th ed. Burlington, MA: Elsevier; 2007.
28. Kilpatrick IC, Jones MW, Phillipson OT. Asemiautomated analysis method for catecholamines, indoleamines, and some prominent metabolites in microdissected regions of the nervous system: an isocratic HPLC technique employing coulometric detection and minimal sample preparation. J Neurochem. 1986;46(6):1865-1876. (Pubitemid 16095494)
29. Bishop C, Taylor JL, Kuhn DM, Eskow KL, Park JY, Walker PD. MDMA and fenfluramine reduce L-DOPA-induced dyskinesia via indirect5-HT1 A receptor stimulation. Eur J Neurosci. 2006;23(10):2669-2676. (Pubitemid 43801458)
30. Dupre KB, Eskow KL, Steiniger A, et al. Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemiparkinsonian rat. Psychopharmacology. 2008;199(1):99-108.
31. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitativePCRand the 2∧-δδ Ct method. Methods. 2001;25:402-408. (Pubitemid 34164012)
32. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):2002-2007.
33. Deak T, Bordner KA, McElderry NK, et al. Stress-induced increases in hypothalamic IL-1: a systematic analysis of multiple stressor paradigms. Brain Res Bull. 2005;64:541-556. (Pubitemid 40082506)
34. Steiner AA, Molchanova AY, Dogan MD, et al. The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors. J Physiol. 2011;589(9):2415-2431.
35. Qiao S, Okret S, Jondal M. Thymocyte-synthesized glucocorticoids play a role in thymocyte homeostasis and are down-regulated by adrenocorticotropic hormone. Endocrinology. 2009;150(9):4163-4169.
36. Bell LJ, Iversen LL, Uretsky NJ. Time course of the effects of 6-hydroxydopamine on catecholamine-containing neurones in rat hypothalamus and striatum. Br J Pharmacol. 1970;40(4):790-799.
37. Robinson TE, Mocsary Z, Camp DM, Whishaw IQ. Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system. J Neurosci. 1994;14(5 Pt 1):2687-2696. (Pubitemid 24140895)
38. Cunningham ET Jr, Bohn MC, Sawchenko PE. Organization of adrenergic inputs to the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J Comp Neurol. 1990;292(4):651-667. (Pubitemid 20076644)
39. Cunningham ET Jr, Sawchenko PE. Anatomical specificity of nor-adrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol. 1988;274(1):60-76.
40. Holguin A, FrankMG,Biedenkapp JC, et al. Characterization of the temporo-spatial effects of chronic bilateral intrahippocampal cannulae on interleukin-1β. J Neurosci Methods. 2007;161(2):265-272. (Pubitemid 46466954)
41. Lightman S, Todd K, Everitt B. Ascending noradrenergic projections from the brainstem: evidence for a major role in the regulation of blood pressure and vasopressin secretion. Exp Brain Res. 1984;55(1):145-151. (Pubitemid 14081841)
42. Feldman S, Weidenfeld J. Depletion of hypothalamic norepinephrine and serotonin enhances the dexamethasone negative feedback effect on adrenocortical secretion. Psychoneuroendocrinology. 1991;16(5):397-405.
43. Abercrombie ED, Zigmond MJ. Partial injury to central noradrenergic neurons: reduction of tissue norepinephrine content is greater than reduction of extracellular norepinephrine measured by microdialysis. J Neurosci. 1989;9(11):4062-4067. (Pubitemid 20004900)
44. Johnson JD, Campisi J, Sharkey C, et al. Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience. 2005;135:1295-1307. (Pubitemid 41416690)
45. Ma XM, Levy A, Lightman SL. Rapid changes in heteronuclear RNA for corticotrophin-releasing hormone and arginine vasopressin in response to acute stress. J Endocrinol. 1997;152(1):81-89. (Pubitemid 27026390)
46. Ma X-M, Aguilera G. Transcriptional responses of the vasopressin and corticotropin-releasing hormone genes to acute and repeated intraperitoneal hypertonic saline injection in rats. Mol Brain Res. 1999;68(1-2):129-140. (Pubitemid 29244001)
47. Pace TWW, Gaylord RI, Jarvis E, Girotti M, Spencer RL. Differential glucocorticoid effects on stress-induced gene expression in the paraventricular nucleus of the hypothalamus and ACTH secretion in the rat. Stress (Amsterdam, Netherlands). 2009;12(5):400-411.
48. Deak T. Immune cells and cytokine circuits: toward a working model for understanding direct immune-to-adrenal communication pathways. Endocrinology. 2008;149(4):1433-1435. (Pubitemid 351468302)
49. Franchimont D, Bouma G, Wolkersdörfer GW, et al. Adrenal cortical activation in murine colitis. Gastroenterology. 2000;119(6):1560-1568. (Pubitemid 32198681)
50. Arakawa H, Arakawa K, Blandino P Jr, Deak T. The role of neuroinflammation in the release of aversive odor cues from footshockstressed rats: implications for the neural mechanism of alarm pheromone. Psychoneuroendocrinology. 2011;36(4):557-568.
51. Blandino P Jr, Barnum CJ, Deak T. The involvement of norepinephrine and microglia in hypothalamic and splenic IL-1B responses to stress. J Neuroimmunol. 2006;173:87-95.
52. Deak T, Bellamy C, Bordner KA. Protracted increases in core body temperature and interleukin-1 following acute administration of lipopolysaccharide: implications for the stress response. Physiol Behav. 2005;85(3):296-307. (Pubitemid 40840746)
53. Ulrich-Lai YM, Arnhold MM, Engeland WC. Adrenal splanchnic innervation contributes to the diurnal rhythm of plasma corticosterone in rats by modulating adrenal sensitivity to ACTH. Am J Physiol Regul Integr Comp Physiol. 2006;290(4):R1128-R1135.
54. Charlton BG. Adrenal cortical innervation and glucocorticoid secretion. J Endocrinol. 1990;126(1):5-8. (Pubitemid 20203858)
55. Whitworth EJ, Kosti O, Renshaw D, Hinson JP. Adrenal neuropeptides: regulation and interaction with ACTH and other adrenal regulators. Microsc Res Technique. 2003;61(3):259-267. (Pubitemid 36618452)
56. Zhong M-K, Duan Y-C, Chen A-D, et al. Paraventricular nucleus is involved in the central pathway of cardiac sympathetic afferent reflex in rats. Exp Physiol. 2008;93(6):746-753. (Pubitemid 351678597)
57. Hori T, Fukuda M, Suzuki H, Yano S, Ono T. SART stress effects on lymphocytes in the thymus and spleen of normal, adrenalectomized, and sympathectomized mice. Clin Immunol Immunopathol. 1993;68(3):243-255. (Pubitemid 23284083)
58. Mohn CE, Fernandez-Solari J, De Laurentiis A, et al. The rapid release of corticosterone from the adrenal induced by ACTH is mediated by nitric oxide acting by prostaglandin E2. Proc Natl Acad Sci USA. 2005;102(17):6213-6218. (Pubitemid 40594280)
59. Bornstein SR, Engeland WC, Ehrhart-Bornstein M, Herman JP. Dissociation of ACTH and glucocorticoids. Trends Endocrinol Metab. 2008;19(5):175-180. (Pubitemid 351847836)
60. Spiga F, Harrison LR, Wood S, et al. Blockade of the V1b receptor reduces ACTH, but not corticosterone secretion induced by stress without affecting basal hypothalamic-pituitary-adrenal axis activity. J Endocrinol. 2009;200:273-283.